Predictive value of vascular endothelial growth factor A (VEGF-A) for bevacizumab-based treatments across advanced cancers: a meta-analysis based on eight phase III randomized control trials involving 4,523 patients
2021 ◽
Vol 157
◽
pp. 103186
2012 ◽
Vol 76
(6)
◽
pp. 464-471
◽
2008 ◽
Vol 46
(12)
◽
pp. 840-846
◽
2016 ◽
Vol 57
(4)
◽
pp. 1798
◽
2012 ◽
Vol 18
(17)
◽
pp. 4526-4537
◽